0.00
Keen Vision Acquisition Corporation (KVACU) 最新ニュース
Boothbay Fund Management LLC Sells 52,370 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Learn to Evaluate (KVAC) using the Charts - news.stocktradersdaily.com
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Up 33.3% in April - MarketBeat
AQR Arbitrage LLC Sells 230,549 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Berkley W R Corp Trims Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Quarry LP Lowers Stake in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition extends merger deadline By Investing.com - Investing.com Canada
KVAC stock soars to all-time high, reaching $11.28 By Investing.com - Investing.com South Africa
Spartan Fund Management Inc. Makes New Investment in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 - Investing.com
Keen Vision Acquisition extends merger deadline - Investing.com Australia
Medera to Go Public through Merger with KVAC - CHEManager
KVACWKeen Vision Acquisition Corp Latest Stock News & Market Updates - Stock Titan
Long Term Trading Analysis for (KVAC) - news.stocktradersdaily.com
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 62.5% in March - MarketBeat
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of PLYA, LTRPA, MHLD, KVAC to Act Now - Morningstar
Yakira Capital Management Inc. Buys New Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.26 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.26 amid market optimism By Investing.com - Investing.com South Africa
(KVAC) Investment Report - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Medera presents updated results from gene therapy trial for heart failure - TipRanks
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Significant Growth in Short Interest - MarketBeat
KVAC stock soars to all-time high, touches $11.25 By Investing.com - Investing.com Canada
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline By Investing.com - Investing.com Australia
KVAC stock soars to all-time high, touches $11.25 - Investing.com
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline - Investing.com
Mizuho Securities USA LLC Cuts Stock Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Trading 0.2% HigherStill a Buy? - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Shares Up 0.2% – What’s Next? - Defense World
BioStem Technologies (OTCMKTS:BSEM) Shares Up 7.1% – What’s Next? - Defense World
KVAC stock soars to all-time high of $11.19 amid market optimism - Investing.com Australia
KVAC stock soars to all-time high of $11.19 amid market optimism By Investing.com - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):